Dr Michael Chang, founder and chairman of OBI Pharma, shares the history of his company’s beginnings and highlights the current progress of its innovative immune-oncology pipeline. Dr Chang goes on to comment on the condition of the Asian market while explaining his vision for OBI as a biotech role model in strategy, quality, and patient care.
We were hoping to act as a role model for Taiwan and show that despite being a small country with a small market and limited market capital, biotech is possible
